Trial Profile
A phase III randomized, double blind, multi-center study of Xylentra_?_ versus Silver Sulfadiazine for efficacy and safety in patients with partial thickness burns in India
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Jul 2019
Price :
$35
*
At a glance
- Drugs Genopep (Primary)
- Indications Burns
- Focus Therapeutic Use
- Sponsors Issar Pharma
- 08 Jul 2015 New trial record